Howard Colman, MD, PhD, has multiple clinical interests including the treatment of primary and metastatic brain tumors, and the diagnosis and management of neurologic complications of cancer. His clinical research is focused on the development and testing of new therapies for brain tumors. His laboratory interests include the identification of molecular markers of prognosis and treatment response in brain tumors and the role of tumors stem cells in the development and treatment resistance of brain tumors. He is an associate professor in the Department of Neurosurgery, a member of the multidisciplinary Brain Tumor Research Team, and is Director of Medical Neuro-Oncology at Huntsman Cancer Institute.
View More